New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
MILAN, Oct. 10, 2026 /PRNewswire/ -- From October 06 to 08, 2026, Kexing Biopharm (688136.SH) exhibited at CPHI Milan 2026, showcasing its global innovative drug pipeline, co-developed biosimilars, and a broad portfolio of products commercialized in overseas markets. During the event, the Company engaged with drug purchasers, biotechs, and industry partners from...
RingConn Receives FDA 510(k) Clearance for Non-Invasive Blood Oxygen (SpO2) Measurement
Shenzhen, China, Oct. 10, 2026 /PRNewswire/ -- Shenzhen Ninenovo Technology Limited, the parent company of RingConn, announced that its Smart Ring has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for non-invasive blood oxygen (SpO2) measurement (Clearance No. K260490). RingConn Smart Ring This clearance marks a significant milestone for RingConn in the FDA-cleared...
First Patient Dosed in Phase III Perioperative Study of Cadonilimab (PD-1/CTLA-4) in Colon Cancer
HONG KONG, Oct. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-40/AK104-313) evaluating cadonilimab, its first-in-class PD-1/CTLA-4 bispecific antibody, as monotherapy in the neoadjuvant/adjuvant (perioperative) treatment of resectable microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) colon cancer. This marks a significant...
POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination
GUANGZHOU, China, Oct. 10, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (Nasdaq: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today announced that it received a staff determination letter (the "Letter") from the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") on October 6, 2026....
Invetech & MeMed win 2026 Good Design Award Gold for MeMed Key™
Award recognizes innovation, design excellence, and impact in Engineering Design SAN DIEGO, Oct. 9, 2026 /PRNewswire/ -- Invetech, a product realization company that designs, engineers and manufactures fully customizable platforms, announced that its work on the MeMed Key™ has been recognized with a 2026 Gold Good Design Award in the...
MIDEA COMPLETES THE ACQUISITION OF ESAOTE
Midea Group marks its commitment to healthcare and innovation by completing the acquisition of Esaote GENOA, Italy, Oct. 9, 2026 /PRNewswire/ -- Esaote S.p.A., a leader in the medical imaging sector, announces the completion of the controlling stake acquisition of its share capital by Midea – the Chinese global technology...
Dr. Vein, a Specialist Varicose Vein Clinic in Ho Chi Minh City, Sets Out Its Treatment Pathway for Patients Travelling from the United States
HO CHI MINH CITY, Vietnam, Oct. 9, 2026 /PRNewswire/ -- Dr. Vein Clinic, a medical facility in central Ho Chi Minh City specializing in the examination and treatment of varicose veins, has set out the treatment pathway it uses for patients who travel to Vietnam for care. The clinic treats lower limb venous insufficiency with minimally invasive methods:...
International Couples in Japan Explore Fertility Options in Taiwan and the U.S.
TOKYO, TAIPEI and SHANGHAI, Oct. 9, 2026 /PRNewswire/ -- As international marriages and cross-border relocation increase, couples living in Japan are showing growing interest in fertility care in Taiwan and the United States. For Chinese-speaking families, Taiwan offers an option for preliminary procedures, including fertility evaluations, egg retrieval, and embryo culture, before exploring further treatment options in the...
Lucy Liu Joins Merz Aesthetics to Launch ‘Your Time is Now’, Inspiring a New Conversation on Aging Well Across Asia Pacific
The regional campaign introduces The Proudly Becoming Collection by Merz Aesthetics Asia Pacific, powered by SkinGivity Solutions®, supporting a more integrative approach to medical aesthetics focused on skin longevity and personalized, natural-looking results. HONG KONG, Oct. 9, 2026 /PRNewswire/ -- Merz Aesthetics, the world's largest dedicated medical aesthetics company, today unveiled...
Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026
SHANGHAI and HONG KONG, Oct. 9, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies indications, today announced that it will release the latest preclinical results...
